While I don't buy into the boundless pessimism of Dhukka and some others, I do think it is now incumbent on management to tell us just what is going on, especially with the cellulite cream.
Sure, it's all well and good to extoll the potential of AOD9604 - I've been doing that since 2002. But, AOD9604 has a history of disappointing. Is it not too much to ask that we get a look at the results of the focus group testing - even if only a summary with a typical before and after comparison?
I'd like to have some indication of how this product, upon which so much is riding right now, has worked in the real world before splurging on the new boat, if you get my drift.
I am disappointed that the company has not followed hard behind the placement with updates and releases. I am at a loss to explain why they have had no follow through.
But, glutton for punishment that I am, I'll wait for as long as it takes.
POH Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)